Israeli drug maker Teva struck a deal with a Tel Aviv-based start-up to give patients an exclusive marijuana inhaler, which allows users to control the amount of the drug they consume.On Monday, one of the world’s largest drug companies, Teva Pharmaceutical Industries, signed an agreement with Syqe Medical to distribute a unique cannabis treatment technology. The pocket-sized device can be loaded with selective-dose cartridges, allowing patients to take an optimal dose of the drug.
h/t Goneviral
Views: